Delivery Order SPE2DR25D2005-SPE2DR26FF1M0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $22,761.00 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents one of multiple pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,274.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on January 23, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of February 13, 2026. This is a competitively awarded contract with no set-aside designation, and performance will take place at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency awarded a delivery order valued at $11,630.70 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, effective January 7, 2026, with an ultimate completion date of January 29, 2026, represents a firm fixed-price procurement with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,822.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on January 20, 2026, with an ultimate completion date of February 10, 2026. The contract is not set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $63,705.00 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without set-aside restrictions and carries a firm fixed-price structure, with performance scheduled for completion by February 12, 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $52,128 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The order, issued on September 22, 2025, with an ultimate completion date of October 14, 2025, represents a firm fixed-price, competitively awarded procurement with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $183,470.40 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, non-set-aside contract was awarded on January 20, 2026, with an ultimate completion date of February 10, 2026. The vaccine will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $147,806.89 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract is firm fixed price with no set-aside designation, issued on December 30, 2025, and scheduled for ultimate completion by January 22, 2026. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the nation's largest...
- The Defense Logistics Agency awarded a delivery order valued at $88,906.40 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, designated as a firm fixed-price delivery order, was awarded on January 6, 2026, with an ultimate completion date of January 28, 2026. The vendor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This non-competitive delivery order was issued without a set-aside designation, indicating it was...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF1M0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,548.22 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The order was issued on January 23, 2026, with an ultimate completion date of February 13, 2026, and utilizes firm fixed-price pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 31, 2031. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a broad portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. The company was competitively selected to fulfill this vaccine order, consistent with its established role as a primary vendor within the DLA's global pharmaceutical support network. This relatively small-value delivery order exemplifies the company's ongoing capability to provide essential medical commodities to support military healthcare programs and Defense Department medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/22/26 |